Elahere 100 mg/20 mL (5 mg/mL) injection Images

Generic Name: mirvetuximab soravtansine

This medication has been identified as Elahere 100 mg/20 mL (5 mg/mL) injection and is used for Ovarian Cancer, Peritoneal Cancer, and Fallopian Tube Cancer. It belongs to the drug class miscellaneous antineoplastics and is not a controlled substance.

Images of medication

Elahere

Generic Name

mirvetuximab soravtansine

Strength

100 mg/20 mL (5 mg/mL) injection

Availability

Prescription only

Drug Class

Miscellaneous antineoplastics

CSA Schedule

Not a controlled drug

Labeler / Supplier

ImmunoGen, Inc.

National Drug Code (NDC)

72903-0853

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer